Journal Article (Review Article) DZNE-2021-01189

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Glial Purinergic Signaling in Neurodegeneration.

 ;  ;  ;  ;  ;

2021
Frontiers Research Foundation Lausanne

Frontiers in neurology 12, 654850 () [10.3389/fneur.2021.654850]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Purinergic signaling regulates neuronal and glial cell functions in the healthy CNS. In neurodegenerative diseases, purinergic signaling becomes dysregulated and can affect disease-associated phenotypes of glial cells. In this review, we discuss how cell-specific expression patterns of purinergic signaling components change in neurodegeneration and how dysregulated glial purinergic signaling and crosstalk may contribute to disease pathophysiology, thus bearing promising potential for the development of new therapeutical options for neurodegenerative diseases.

Keyword(s): ATP ; Alzheimer ; adenosine ; astrocyte ; microglia ; neurodegeneration ; oligodendrocyte ; purine

Classification:

Contributing Institute(s):
  1. Microglia and Neuroinflammation (AG Halle)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2021
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; OpenAccess ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Halle
Full Text Collection
Public records
Publications Database

 Record created 2021-09-21, last modified 2024-03-28


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)